Home›Companies›Biotech & Pharma›AssayQuant Technologies

AssayQuant Technologies, Inc.

Updated Oct 29, 2026·Latest SEC filing Jul 25, 2023·Suggest an edit

About AssayQuant Technologies

AssayQuant Technologies is a private company based in Marlboro, Maryland. It has reported $9,622,385 raised in two offerings on Form D since May 2021. Its chief executive is Erik Schaefer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 7, 2023Jul 10, 2023amended Jul 25, 2023$5,122,385of $12.0M target21$243KDebtRule 506(c)Form D/A ↗1 earlier filing
May 5, 2021May 14, 2021$4,500,000fully sold9$500KEquityRule 506(b)Form D ↗
Total, two offerings$9,622,385

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AssayQuant Technologies's Form D filed Jul 25, 2023.

GP
Gil Price
Director
JH
ES
Erik Schaefer
President, CEO, and CSO
CB

Sources

  1. SECAssayQuant Technologies, Inc. Form D, filed Jul 10, 2023
  2. SECAssayQuant Technologies, Inc. filing history